Answers are grounded in this paper and cite their sources.
Background: Hereditary Hemochromatosis (HH) can lead to complications including cirrhosis, diabetes and osteoporosis and pituitary dysfunction.The recommended initial treatment is phlebotomy adjusted based on ferritin levels.The extent to which HH affects the quality of life is not known. Aim:To evaluate the quality of life patients with HH. Methods:We included all patients with genetically verified HH undergoing phlebotomy at four clinical sites in Denmark.Evidence of complications was systematically assessed.Quality of life was assessed using the Short Form 36 (SF-36) questionnaire.Predictors of the quality of life (SF-36 total score) were evaluated in univariable and multivariable regression analysis.Results: Twenty five patients (median age 60 years; 13 men) were included.The median number of times patients underwent phlebotomy in the year before inclusion was 6 (range 4-8).Four patients had impaired glucose tolerance, two had diabetes, nine had a borderline response to the Synacthen test and two had evidence of hypogonadotropic hypogonadism.In multivariable regression analyses, only ferritin was a significant predictor of the quality of life (P=0.031).Conclusion: This study found that a low ferritin may be having a detrimental effect on the quality of life in patients with HH.Based on the small sample size, we cannot make any definite conclusions.The results suggest that the quality of life may be considered when evaluating treatment goals, e.g., in the elderly with a low risk of complications, but additional research is needed to evaluate our findings.
No takes yet. Share an insight, caveat, or question.
Lise Lotte Gluud (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: